Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sensible Medical Innovations

Explore full profile

Remote monitoring of lung fluid using #ReDS™ medical radar technology- an accurate, absolute and actionable way to measure lung fluid #heartfailure

Netanya, IsraelFounded 2007Health Tech & Medtech
Valuation $0–100M Latest valuation · 2019
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sensible Medical Innovations and the history behind them.

About Sensible Medical Innovations

Sensible Medical is a pioneering startup specializing in noninvasive monitoring systems for managing lung fluid in patients with heart failure. The company's flagship product, ReDS (Radar-based technology), provides accurate, absolute, and actionable measurements of lung fluid, which is crucial for assessing the clinical status of heart failure patients. This technology is designed to be easy to use and offers a cost-effective solution for healthcare providers, payers, and patients alike.

Read full description

Sensible Medical primarily serves three types of clients: healthcare providers (such as hospitals and clinics), payers (insurance companies), and patients. For healthcare providers, the ReDS system aids in making informed decisions and improving patient care by providing precise lung fluid measurements. This can lead to better management of heart failure, potentially reducing hospital readmissions and associated costs. For payers, the system offers an end-to-end service that can significantly cut down on medical expenses by enabling more effective management of chronic heart conditions. Patients benefit from the technology by receiving better-managed care, which helps them stay safe at home and reduces the need for frequent hospital visits.

Operating in the healthcare technology market, Sensible Medical's business model revolves around selling its ReDS system to healthcare providers and payers. The company generates revenue through the sale of its devices and possibly through service agreements for ongoing support and maintenance.

In summary, Sensible Medical is at the forefront of noninvasive medical technology, offering a vital tool for managing heart failure. Its innovative approach not only enhances patient care but also provides economic benefits to healthcare providers and payers.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2007
Headquarters
Netanya, Israel
Employees
33
Open positions
None listed
Dealroom signal
64.8/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Defence, Cardiology and cardiovascular, Pulmonary, Lungs
Technology
Artificial Intelligence, Deep Tech, Computer Vision, Connected Device, Recognition Technology, IoT InternetOfThings
Business model
Manufacturing
Client focus
b2b

Latest news

Press, funding announcements and product moves mentioning Sensible Medical Innovations.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCEquity / VC Jun 2019 $10M $40M Medicure
EARLY VCEquity / VC Nov 2013 $20M $80M SCP Vitalife Partners · Genesis Partners · Boston Scientific
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

Sensible Medical Innovations website traffic

Latest recorded traffic for Sensible Medical Innovations is 420 monthly website visits, down 88.3% over the last three months. Sensible Medical Innovations's team declined 8.3% over the past year.

Latest monthly visits420 3-month web change-88.3% 1-year team growth-8.3%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Cleveland Clinic

Series A3 investors entered at this stage

Series B and later1 investor entered at this stage

  • Medicure
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇮🇱 Israel71.4%
🇺🇸 United States28.6%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sensible Medical Innovations on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sensible Medical Innovations’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.